Clinical Trials › NCT04267926
Active, Not RecruitingPhase 1
MitoQ for Fatigue in Multiple Sclerosis (MS)
Sponsored by VA Office of Research and Development
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 45
Target enrollment
1
U.S. states
Apr 2020
Start date
Mar 2026
Expected completion
Interventions / Treatments
20 mg MitoQPlacebo40mg of MitoQ
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Oregon1 site
Portland
MS centers in Oregon
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Oregon centersMore Phase 1 trials
Browse all Phase 1 MS trialsCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
